All News #Library
Rare Diseases
Purespring Gets FDA IND Clearance for IgAN Phase I/II Trial
09 Jul 2025 //
GLOBENEWSWIRE
Purespring Therapeutics granted EMA orphan drug for IgA Nephropathy
28 Apr 2025 //
GLOBENEWSWIRE
Purespring Therapeutics granted EMA orphan drug for IgAN
28 Apr 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support